chrX-48792042-G-A
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The ENST00000376670.9(GATA1):c.419G>A(p.Arg140Gln) variant causes a missense change. The variant allele was found at a frequency of 0.0000132 in 1,210,040 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 4 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R140W) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000376670.9 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GATA1 | NM_002049.4 | c.419G>A | p.Arg140Gln | missense_variant | 3/6 | ENST00000376670.9 | NP_002040.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GATA1 | ENST00000376670.9 | c.419G>A | p.Arg140Gln | missense_variant | 3/6 | 1 | NM_002049.4 | ENSP00000365858 | P4 |
Frequencies
GnomAD3 genomes AF: 0.0000179 AC: 2AN: 111853Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34043
GnomAD3 exomes AF: 0.00000545 AC: 1AN: 183417Hom.: 0 AF XY: 0.0000147 AC XY: 1AN XY: 67861
GnomAD4 exome AF: 0.0000127 AC: 14AN: 1098187Hom.: 0 Cov.: 33 AF XY: 0.0000110 AC XY: 4AN XY: 363561
GnomAD4 genome AF: 0.0000179 AC: 2AN: 111853Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34043
ClinVar
Submissions by phenotype
Diamond-Blackfan anemia;C1845837:GATA binding protein 1 related thrombocytopenia with dyserythropoiesis Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 16, 2017 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). This variant has not been reported in the literature in individuals with GATA1-related disease. This variant is not present in population databases (ExAC no frequency). This sequence change replaces arginine with glutamine at codon 140 of the GATA1 protein (p.Arg140Gln). The arginine residue is moderately conserved and there is a small physicochemical difference between arginine and glutamine. - |
Beta-thalassemia-X-linked thrombocytopenia syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Baylor Genetics | Feb 22, 2019 | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at